TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Closed Labor Day 09-04 16:00:00 EDT

2.21

-0.03

-1.34%

盘后2.17

-0.04-1.81%

19:30 EDT

High2.23	Low2.18	Vol8.81K
Open2.23	D1 Closing2.24	Amplitude2.23%
Mkt Cap25.58M	Tradable Cap20.98M	Total Shares11.57M
T/O19.41K	T/O Rate0.09%	Tradable Shares9.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":2.21,"timestamp":1788552000000,"preClose":2.24,"halted":0,"volume":8809,"hourTrading":{"tag":"盘后","latestPrice":2.17,"preClose":2.21,"latestTime":"19:30 EDT","volume":1036,"amount":2248.8428,"timestamp":1788564603960,"change":-0.04,"changeRate":-0.0181,"amplitude":0.0181},"delay":0,"changeRate":-0.013392857142857253,"floatShares":9491800,"shares":11574362,"eps":-0.018748334,"marketStatus":"Closed Labor Day","change":-0.03,"latestTime":"09-04 16:00:00 EDT","open":2.23,"high":2.23,"low":2.18,"amount":19411.4824494,"amplitude":0.022321,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.018748334,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":2.24,"postHourTrading":{"tag":"盘后","latestPrice":2.17,"preClose":2.21,"latestTime":"19:30 EDT","volume":1036,"amount":2248.8428,"timestamp":1788564603960,"change":-0.04,"changeRate":-0.0181,"amplitude":0.0181},"volumeRatio":0.27364791282312734,"impliedVol":0.8994,"impliedVolPercentile":0.3889},"requestUrl":"/m/hq/s/TXMD","defaultTab":"news","newsList":[{"id":"2665354649","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354649?lang=en_us&edition=fundamental","pubTime":"2026-09-05 05:30","pubTimestamp":1788557400,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841843","title":"TherapeuticsMD Inc. Stock Climbs 4.1%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841843","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:35","pubTimestamp":1788381300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. advanced 4.1% to $2.26 on what proved to be an all-around positive trading ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885584","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885584","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885584?lang=en_us&edition=fundamental","pubTime":"2026-09-01 05:31","pubTimestamp":1788211860,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035722","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035722?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:31","pubTimestamp":1787866260,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752353","title":"TherapeuticsMD Inc. Stock Rallies 10.1%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752353","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752353?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:32","pubTimestamp":1787689920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. jumped 10.1% to $2.28 on what proved to be an all-around favorable trading ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661023771","title":"TherapeuticsMD Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2661023771","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661023771?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:32","pubTimestamp":1787261520,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437657","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437657","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437657?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:31","pubTimestamp":1787002260,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659915189","title":"Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September","url":"https://stock-news.laohu8.com/highlight/detail?id=2659915189","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659915189?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:41","pubTimestamp":1786621315,"startTime":"0","endTime":"0","summary":"Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into SeptemberOverviewCancer drug developer's Q2 revenue declined yr/yr as license and other revenue fellU.S. XPOVIO net pro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","KURA","TXMD","BK4505","KPTI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659567411","title":"Indaptus Q2 Net Loss Narrows as Costs Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659567411","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659567411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:16","pubTimestamp":1786619798,"startTime":"0","endTime":"0","summary":"Indaptus Q2 net loss narrows as costs fallOverviewU.S. immunotherapy biotech's Q2 net loss narrowed, driven by lower clinical and payroll costsCompany discontinued Decoy20 clinical study and has no ac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PLRX","INDP","BK4139","TXMD","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658468269","title":"Canada's Cipher Pharma Q2 Revenue Falls on Lower Natroba Sales Amid Reduced Medicaid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658468269","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658468269?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:11","pubTimestamp":1786482690,"startTime":"0","endTime":"0","summary":"Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverageOverviewCanada specialty pharma firm's Q2 revenue fell 10% yr/yr, missing analyst expectationsAdjusted EBIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N44812Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4007","TXMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945631","title":"TherapeuticsMD Q2 Results and Strategic Alternatives Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945631?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:41","pubTimestamp":1786480888,"startTime":"0","endTime":"0","summary":"TherapeuticsMD ( ($TXMD) ) has issued an update. On August 11, 2026, TherapeuticsMD reported second quarter 2026 results for the period ended June ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-q2-results-and-strategic-alternatives-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-q2-results-and-strategic-alternatives-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658788943","title":"TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2658788943","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658788943?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:30","pubTimestamp":1786480244,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year.  The company reported $869.000 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61127788/therapeuticsmd-q2-eps-0-01-down-0-05-yoy-sales-869-000k-down-952-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948753","title":"TherapeuticsMD Q2 License Revenue Falls; Continues to Evaluate Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948753","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948753?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:09","pubTimestamp":1786478962,"startTime":"0","endTime":"0","summary":"TherapeuticsMD Q2 license revenue falls; continues to evaluate strategic alternativesOverviewUS pharmaceutical royalty company's Q2 license revenue declined yr/yr due to lower licensed product salesNe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4139","BK4007","TXMD","LBRX","ENTA","XTNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658094306","title":"TherapeuticsMD Q2 2026 Earnings: License Revenue and Net Income Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2658094306","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658094306?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:03","pubTimestamp":1786478587,"startTime":"0","endTime":"0","summary":"TherapeuticsMD reported Q2 2026 license revenue of $864,000, down from $952,000 a year earlier, as sales of licensed products changed. Net income from continuing operations fell to $164,000 from $545,000, while operating expenses rose to $1.685 million. Cash and cash equivalents were $9.2 million at June 30, 2026. An IMVEXXY milestone of CAD 500,000, approximately US$364,800, will be recognized in Q3, and the company continues evaluating strategic alternatives without a timetable. The quarter highlighted dependence on licensee product sales and uneven milestone timing.","market":"hk","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262096912-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658483849","title":"TherapeuticsMD Q2 FY26 Laba Bersih Turun Ke US$ 164.000; Revenue Lisensi Turun Ke US$ 864.000","url":"https://stock-news.laohu8.com/highlight/detail?id=2658483849","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658483849?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:00","pubTimestamp":1786478432,"startTime":"0","endTime":"0","summary":"TherapeuticsMD Q2 FY26 laba bersih turun ke US$ 164.000; revenue lisensi turun ke US$ 864.000TherapeuticsMD membukukan laba bersih dari operasi berlanjut US$ 164.000 pada kuartal II 2026, turun dari U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL1bDQkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657579283","title":"TherapeuticsMD Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657579283","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657579283?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:31","pubTimestamp":1785965460,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811133","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811133?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:31","pubTimestamp":1785447060,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653524938","title":"Therapeuticsmd Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2653524938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653524938?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:31","pubTimestamp":1784583060,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","IE0000B7K699.USD","BK4550","LU2023251221.USD","LU0170899867.USD","LU1244550494.USD","LU2237443978.SGD","LU1244550577.SGD","XLV","LU2129689605.HKD","LU1718418525.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","RXL","LU0943347566.SGD","LU1934455863.HKD","LU2089284900.SGD","LU1732799900.SGD","LU0882574055.USD","LU1989771016.USD","IE000WAW04H5.SGD","FHLC","LU0472753341.HKD","TXMD","BK4588","PJP","IXJ","LU1923622614.USD","BK4559","PPH","LU0661504455.SGD","LU1061106388.HKD","LU0965508806.USD","JDOC","IE00B19Z3B42.SGD","LU0912757837.SGD","BK4585","IE00BLSP4239.USD","LU0211328371.USD","ABBV","MEDX","IE00BDGV0183.EUR","IYH","LU0098860793.USD","LU0417517546.SGD","FTXH","VHT","LU0320765646.SGD","LU2125909247.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651499931","title":"Therapeuticsmd Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651499931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651499931?lang=en_us&edition=fundamental","pubTime":"2026-07-16 05:29","pubTimestamp":1784150940,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Therapeutics","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU0289961442.SGD","VHT","LU1244550577.SGD","LU1551013342.USD","IE00BVYPNV92.GBP","LU2089284900.SGD","LU0029864427.USD","PPH","IYH","IE0009355771.USD","TXMD","LU1732799900.SGD","LU0069063385.USD","LU1670628061.USD","LU2089984988.USD","RXL","IE00BBT3K403.USD","IE000MB6IJN5.SGD","BK4007","LU2112291526.USD","LU1162221912.USD","XLV","LU1983299246.USD","LU0545039389.USD","LU1430594728.SGD","LU0211328371.USD","LU0943347566.SGD","MEDX","IE00BVYPNW00.USD","LU0256863902.USD","LU1551013425.SGD","LU2129689514.USD","LU2237443978.SGD","IE00BLSP4239.USD","FTXH","LU1037948541.HKD","LU1934455863.HKD","FHLC","PJP","LU0234570918.USD","LU0942090050.USD","IE00B2B36J28.USD","ABBV","LU2237443622.USD","IE00B3PB1722.GBP","SG9999003800.SGD","AGNG","JDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651014239","title":"Therapeuticsmd Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651014239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651014239?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:30","pubTimestamp":1783978200,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","VHT","IE000WAW04H5.SGD","IE00BSNM7G36.USD","LU2237443382.USD","PPH","IYH","IE00B42XCP33.USD","LU0456855351.SGD","LU1093756325.SGD","LU2347655156.SGD","LU1037948897.HKD","TXMD","LU1989771016.USD","LU0057025933.USD","BK4139","LU0058720904.USD","LU0511384066.AUD","RXL","LU0965509010.AUD","BK4007","LU2133065610.SGD","LU1718418525.SGD","XLV","SG9999015952.SGD","BK4533","LU1983299246.USD","LU1430594728.SGD","LU1585245621.USD","LU0211328371.USD","LU0289739699.SGD","MEDX","SG9999015945.SGD","LU0124676726.USD","LU2237443549.SGD","FTXH","BK4566","LU0128525929.USD","FHLC","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0965509283.SGD","PJP","IE00BN8TJ469.HKD","ABBV","SG9999003800.SGD","LU0203347892.USD","AGNG","JDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":0.0676},{"period":"3month","weight":0.1106},{"period":"6month","weight":-0.0178},{"period":"1year","weight":1.0463},{"period":"ytd","weight":0.3558}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.069114},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.035452},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.013291},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.016451},{"month":5,"riseRate":0.571429,"avgChangeRate":0.00831},{"month":6,"riseRate":0.571429,"avgChangeRate":0.003424},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.04601},{"month":8,"riseRate":0.5,"avgChangeRate":0.047637},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.022497},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.071876},{"month":11,"riseRate":0.615385,"avgChangeRate":0.054051},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.035764}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}